Ayala Pharmaceuticals Inc (ADXS)

[mastiffsforlife]

I’ll take a guess and say Amgen bailed because of staffing issues at Advaxis. Good chance they did a walk through or heard employees were heading for the doors. Advaxis was in charge of preparing each patients treatment. So if you don’t have the appropriate staffing or some of your top management were either let go or left on there own. The trial for one probably wasn’t being run smoothly to start but being Amgen I wouldn’t want to take any chances. Furthermore I think Advaxis had an idea this was coming and that is why they decided they would continue the Phase 3 trial that they were talking about winding down just a few months before! Still holding my shares and hoping and praying someone is interested in buying HOT at least and we get something out of this mess. Just like the IST was delayed. I said the HOT trial would most likely not start by the end of 2018 and with one day left it isn’t looking good but not surprised. They are constantly over promising on everything and delivering nothing. I hope things change in 2019 but for now it looks like our days are numbered